{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:50:22Z","timestamp":1793274622527,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54966-3","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:02:50Z","timestamp":1782723770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating whole-genome bisulfite sequencing and TCGA data reveals methylation patterns associated with the MTHFR 677\u2009C >\u2009T Variant"],"prefix":"10.1038","volume":"16","author":[{"given":"Guoping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"JiamingYan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhiChun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"54966_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"FG Bray","year":"2024","unstructured":"Bray, F. G. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer. J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA. Cancer. J. Clin."},{"key":"54966_CR2","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796\u20132810. https:\/\/doi.org\/10.1016\/S0140-6736(16)30512-8 (2016).","journal-title":"Lancet"},{"key":"54966_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones, P. A. & Baylin, S. B. The epigenomics of cancer. Cell 128, 683\u2013692. https:\/\/doi.org\/10.1016\/j.cell.2007.01.029 (2007).","journal-title":"Cell"},{"key":"54966_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2010","unstructured":"Sharma, S., Kelly, T. K. & Jones, P. A. Epigenetics in cancer. Carcinogenesis 31, 27\u201336. https:\/\/doi.org\/10.1093\/carcin\/bgp220 (2010).","journal-title":"Carcinogenesis"},{"key":"54966_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/gad.947102","volume":"16","author":"A Bird","year":"2002","unstructured":"Bird, A. DNA methylation patterns and epigenetic memory. Genes. Dev. 16, 6\u201321. https:\/\/doi.org\/10.1101\/gad.947102 (2002).","journal-title":"Genes. Dev."},{"key":"54966_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome - Biological and translational implications. Nat. Rev. Cancer. 11, 726\u2013734. https:\/\/doi.org\/10.1038\/nrc3130 (2011).","journal-title":"Nat. Rev. Cancer."},{"key":"54966_CR7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/JCO.2005.03.2375","volume":"24","author":"M Sanchez-Carbayo","year":"2006","unstructured":"Sanchez-Carbayo, M., Socci, N. D., Lozano, J., Saint, F. & Cordon-Cardo, C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J. Clin. Oncol. 24, 778\u2013789. https:\/\/doi.org\/10.1200\/JCO.2005.03.2375 (2006).","journal-title":"J. Clin. Oncol."},{"key":"54966_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrurol.2013.89","volume":"10","author":"R Kandimalla","year":"2013","unstructured":"Kandimalla, R., van Tilborg, A. A. & Zwarthoff, E. C. DNA methylation-based biomarkers in bladder cancer. Nat. Rev. Urol. 10, 327\u2013335. https:\/\/doi.org\/10.1038\/nrurol.2013.89 (2013).","journal-title":"Nat. Rev. Urol."},{"key":"54966_CR9","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1158\/1078-0432.CCR-10-2659","volume":"17","author":"T Reinert","year":"2011","unstructured":"Reinert, T. et al. Comprehensive genome methylation analysis in bladder cancer: Identification and validation of novel methylated genes and application of these as urinary tumor markers. Clin. Cancer. Res. 17, 5582\u20135592. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2659 (2011).","journal-title":"Clin. Cancer. Res."},{"key":"54966_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst, P. et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10, 111\u2013113. https:\/\/doi.org\/10.1038\/ng0595-111 (1995).","journal-title":"Nat. Genet."},{"issue":"2","key":"54966_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ajcn\/72.2.324","volume":"72","author":"PM Ueland","year":"2000","unstructured":"Ueland, P. M., Refsum, H., Beresford, S. A. & Vollset, S. E. The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr. 72(2), 324\u2013332. https:\/\/doi.org\/10.1093\/ajcn\/72.2.324 (2000).","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"54966_CR12","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/oxfordjournals.aje.a010290","volume":"151","author":"LD Botto","year":"2000","unstructured":"Botto, L. D. & Yang, Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am. J. Epidemiol. 151(9), 862\u2013877. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a010290 (2000).","journal-title":"Am. J. Epidemiol."},{"key":"54966_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/mgme.1998.2714","volume":"64","author":"I Weisberg","year":"1998","unstructured":"Weisberg, I., Tran, P., Christensen, B., Sibani, S. & Rozen, R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64, 169\u2013172. https:\/\/doi.org\/10.1006\/mgme.1998.2714 (1998).","journal-title":"Mol. Genet. Metab."},{"key":"54966_CR14","first-page":"2227","volume":"12","author":"S Kouidhi","year":"2011","unstructured":"Kouidhi, S. et al. MTHFR gene polymorphisms and bladder cancer susceptibility: A meta-analysis including race, smoking status and tumour stage. Asian. Pac. J. Cancer. Prev. 12, 2227\u20132232 (2011).","journal-title":"Asian. Pac. J. Cancer. Prev."},{"key":"54966_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174402","volume":"15","author":"AF Purnomo","year":"2023","unstructured":"Purnomo, A. F. et al. Methylenetetrahydrofolate reductase C677T (rs1801133) polymorphism is associated with bladder cancer in Asian population: Epigenetic meta-analysis as precision medicine approach. Cancers 15, 4402. https:\/\/doi.org\/10.3390\/cancers15174402 (2023).","journal-title":"Cancers"},{"key":"54966_CR16","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3969\/j.issn.1000-484X.2025.07.006","volume":"41","author":"H Juanjuan","year":"2025","unstructured":"Juanjuan, H. et al. Diagnostic value of urine gene methylation combined with folate metabolism gene polymorphism in bladder cancer. Chin. J. immu. 41, 1574\u20131580. https:\/\/doi.org\/10.3969\/j.issn.1000-484X.2025.07.006 (2025).","journal-title":"Chin. J. immu."},{"key":"54966_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L., Han, Y. & He, Q. Clusterprofiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118 (2012).","journal-title":"OMICS"},{"key":"54966_CR18","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.31557\/APJCP.2022.23.5.1465","volume":"23","author":"S Farshid","year":"2022","unstructured":"Farshid, S. et al. Associations of MTHFR rs1801133 (677C>T) and rs180113 (1298A>C) polymorphisms with susceptibility to bladder cancer: a systematic review and meta-analysis. Asian Pac. J. Cancer Prev. 23, 1465\u20131482. https:\/\/doi.org\/10.31557\/APJCP.2022.23.5.1465 (2022).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"54966_CR19","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1073\/pnas.062066299","volume":"99","author":"S Friso","year":"2002","unstructured":"Friso, S. et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Nat. l. Acad. Sci. USA. 99, 5606\u20135611. https:\/\/doi.org\/10.1073\/pnas.062066299 (2002).","journal-title":"Proc. Nat. l. Acad. Sci. USA."},{"key":"54966_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5114\/aoms.2011.20618","volume":"7","author":"M Hosseini","year":"2011","unstructured":"Hosseini, M., Houshmand, M. & Ebrahimi, A. MTHFR polymorphisms and breast cancer risk. Arch. Med. Sci. 7, 134\u2013137. https:\/\/doi.org\/10.5114\/aoms.2011.20618 (2011).","journal-title":"Arch. Med. Sci."},{"key":"54966_CR21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s12029-024-01020-y","volume":"55","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. Association of methylenetetrahydrofolate reductase rs1801133 gene polymorphism with cancer risk and Septin 9 methylation in patients with colorectal cancer. J. Gastrointest. Cancer. 55, 778\u2013786. https:\/\/doi.org\/10.1007\/s12029-024-01020-y (2024).","journal-title":"J. Gastrointest. Cancer."},{"key":"54966_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13546-w","volume":"25","author":"M Ye","year":"2025","unstructured":"Ye, M., Xu, G., Zhang, L., Kong, Z. & Qiu, Z. Meta analysis of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and its association with folate and colorectal cancer. BMC Cancer 25, 169. https:\/\/doi.org\/10.1186\/s12885-025-13546-w (2025).","journal-title":"BMC Cancer"},{"key":"54966_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ajur.2024.09.006","volume":"12","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Deciphering riddles in molecular subtyping of bladder cancer. Asian. J. Urol. 12, 217\u2013231. https:\/\/doi.org\/10.1016\/j.ajur.2024.09.006 (2025).","journal-title":"Asian. J. Urol."},{"key":"54966_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MOU.0000000000000641","volume":"29","author":"U Satyal","year":"2019","unstructured":"Satyal, U., Sikder, R. K., McConkey, D., Plimack, E. R. & Abbosh, P. H. Clinical implications of molecular subtyping in bladder cancer. Curr. Opin. Urol. 29, 350\u2013356. https:\/\/doi.org\/10.1097\/MOU.0000000000000641 (2019).","journal-title":"Curr. Opin. Urol."},{"key":"54966_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.suronc.2019.05.009","volume":"30","author":"Y Bao","year":"2019","unstructured":"Bao, Y., Liu, X., Liu, Y., Wang, S. & Wu, B. Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer. Surg. Oncol. 30, 63\u201371. https:\/\/doi.org\/10.1016\/j.suronc.2019.05.009 (2019).","journal-title":"Surg. Oncol."},{"key":"54966_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048300","volume":"7","author":"T Gao","year":"2012","unstructured":"Gao, T. et al. The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: A systematic review and meta-analysis. PLoS ONE 7, e48300. https:\/\/doi.org\/10.1371\/journal.pone.0048300 (2012).","journal-title":"PLoS ONE"},{"key":"54966_CR27","first-page":"6688","volume":"61","author":"MG Lee","year":"2001","unstructured":"Lee, M. G. et al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer. Res. 61, 6688\u20136692 (2001).","journal-title":"Cancer. Res."},{"key":"54966_CR28","first-page":"8659","volume":"61","author":"R Maruyama","year":"2001","unstructured":"Maruyama, R. et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer. Res. 61, 8659\u20138663 (2001).","journal-title":"Cancer. Res."},{"key":"54966_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-239","volume":"5","author":"ME Reeves","year":"2012","unstructured":"Reeves, M. E. et al. RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1. BMC. Res. Notes. 5, 239. https:\/\/doi.org\/10.1186\/1756-0500-5-239 (2012).","journal-title":"BMC. Res. Notes."},{"key":"54966_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.18632\/oncotarget.26498","volume":"10","author":"YG Amaar","year":"2019","unstructured":"Amaar, Y. G. & Reeves, M. E. RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells. Oncotarget 10, 123\u2013132. https:\/\/doi.org\/10.18632\/oncotarget.26498 (2019).","journal-title":"Oncotarget"},{"key":"54966_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01480-x","volume":"8","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Epigenetic regulation in the tumor microenvironment: Molecular mechanisms and therapeutic targets. Signal. Transduct. Target. Ther. 8, 210. https:\/\/doi.org\/10.1038\/s41392-023-01480-x (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"54966_CR32","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat. Cell. Biol. 21, 978\u2013990. https:\/\/doi.org\/10.1038\/s41556-019-0361-y (2019).","journal-title":"Nat. Cell. Biol."},{"key":"54966_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102530","volume":"115","author":"CM Ascione","year":"2023","unstructured":"Ascione, C. M. et al. Role of FGFR3 in bladder cancer: Treatment landscape and future challenges. Cancer. Treat. Rev. 115, 102530. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102530 (2023).","journal-title":"Cancer. Treat. Rev."},{"key":"54966_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3233\/BLC-200368","volume":"7","author":"D Zhang","year":"2021","unstructured":"Zhang, D., Tian, J., Xia, Q., Yang, Z. & Gu, B. Significance and mechanisms analyses of RB1 mutation in bladder cancer disease progression and drug selection by bioinformatics analysis. Bladder. Cancer. 7, 133\u2013142. https:\/\/doi.org\/10.3233\/BLC-200368 (2021).","journal-title":"Bladder. Cancer."},{"key":"54966_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Cancer epigenetics: From laboratory studies and clinical trials to precision medicine. Cell. Death. Discov. 10, 28. https:\/\/doi.org\/10.1038\/s41420-024-01803-z (2024).","journal-title":"Cell. Death. Discov."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54966-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54966-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54966-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:28:29Z","timestamp":1793273309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54966-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54966"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54966-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article, the affiliations for the authors Juanjuan Hou, Mingliang Guo, Jiaming Yan, Xingzhe Gao and Run Yang were incorrect. The original Article has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was given by the Ethics Committee of The People\u2019s Hospital of Qingyang City\/Qingyang Hospital of the Second Hospital of Lanzhou University(No. 202202\u201301).","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"19756"}}